hexestrol has been researched along with Bone Diseases, Metabolic in 1 studies
Bone Diseases, Metabolic: Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
Excerpt | Relevance | Reference |
---|---|---|
" The often discussed intrinsic estrogen activity of the antiestrogens was present only in the highest dosage tested of tamoxifen." | 1.28 | Antiestrogen and antiandrogen administration reduce bone mass in the rat. ( Bauss, F; Feldmann, S; Lempert, UG; Minne, HW; Parvizi, S; Pfeifer, M; Ziegler, R, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feldmann, S | 1 |
Minne, HW | 1 |
Parvizi, S | 1 |
Pfeifer, M | 1 |
Lempert, UG | 1 |
Bauss, F | 1 |
Ziegler, R | 1 |
1 other study available for hexestrol and Bone Diseases, Metabolic
Article | Year |
---|---|
Antiestrogen and antiandrogen administration reduce bone mass in the rat.
Topics: Androgen Antagonists; Animals; Bone Density; Bone Diseases, Metabolic; Cyproterone; Cyproterone Acet | 1989 |